Matches in SemOpenAlex for { <https://semopenalex.org/work/W2338961167> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2338961167 endingPage "30" @default.
- W2338961167 startingPage "622" @default.
- W2338961167 abstract "In a follow up study of 38 patients with supratentrial malignant glioma verified histologically during the 3 years from 1979 to 1982, the same therapeutic method which was the postoperative synchronized radiation-immunochemotherapy was applied. And we investigated the relationships between the survival rate and the histological malignancy, the operative area, and age of admission. Total dose of 5000 to 6000 rad radiation was given after surgery. 0.02 mg/kg of VCR was administered intravenously on the first and the 29th day of radiation, and 2 mg/kg of ACNU was administered intravenously 24 hours after VCR administration. After synchronized radiotherapy, 2 mg/kg of ACNU was given every 6 weeks and 3 g of PS-K was given orally every day. Dose of PS-K was increased especially during the radiation and for 2 weeks after ACNU administration. This radioimmunochemotherapy was applied to 38 patients with malignant glioma, 25 cases of glioblastoma multiforme, 12 cases of malignant astrocytoma, one cases of malignant ependymoma, one case of malignant oligodendroglioma. A complete clinical course of all patients was observed. 18 of 38 cases are surviving. The survival rate of malignant gliomas was 71.2% for one year, 47.6% for 2 years, 34.8% for 3 years. The survival rate of glioblastoma was 56.3% for one year, 36.9% for 2 years, 12.3% for 3 years. The survival rate of the patients receiving macroscopically total removal was higher than that of the patients receiving subtotal removal. The survival rate of the younger patients (under 49 years old) was higher than that of the older patients (over 50 years old). Side effect of this therapy was myelosupression in 75.8%." @default.
- W2338961167 created "2016-06-24" @default.
- W2338961167 creator A5005344078 @default.
- W2338961167 creator A5043198099 @default.
- W2338961167 creator A5044029123 @default.
- W2338961167 creator A5052678944 @default.
- W2338961167 creator A5059570389 @default.
- W2338961167 creator A5067448995 @default.
- W2338961167 creator A5074133353 @default.
- W2338961167 creator A5077677342 @default.
- W2338961167 creator A5083310363 @default.
- W2338961167 creator A5087019448 @default.
- W2338961167 date "1983-11-01" @default.
- W2338961167 modified "2023-10-14" @default.
- W2338961167 title "[Evaluation of radiation immunochemotherapy in the treatment of malignant glioma. Combined use of ACNU, VCR and PS-K]." @default.
- W2338961167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6584394" @default.
- W2338961167 hasPublicationYear "1983" @default.
- W2338961167 type Work @default.
- W2338961167 sameAs 2338961167 @default.
- W2338961167 citedByCount "0" @default.
- W2338961167 crossrefType "journal-article" @default.
- W2338961167 hasAuthorship W2338961167A5005344078 @default.
- W2338961167 hasAuthorship W2338961167A5043198099 @default.
- W2338961167 hasAuthorship W2338961167A5044029123 @default.
- W2338961167 hasAuthorship W2338961167A5052678944 @default.
- W2338961167 hasAuthorship W2338961167A5059570389 @default.
- W2338961167 hasAuthorship W2338961167A5067448995 @default.
- W2338961167 hasAuthorship W2338961167A5074133353 @default.
- W2338961167 hasAuthorship W2338961167A5077677342 @default.
- W2338961167 hasAuthorship W2338961167A5083310363 @default.
- W2338961167 hasAuthorship W2338961167A5087019448 @default.
- W2338961167 hasConcept C126322002 @default.
- W2338961167 hasConcept C141071460 @default.
- W2338961167 hasConcept C2776194525 @default.
- W2338961167 hasConcept C2776283816 @default.
- W2338961167 hasConcept C2777931997 @default.
- W2338961167 hasConcept C2778227246 @default.
- W2338961167 hasConcept C2778880634 @default.
- W2338961167 hasConcept C2779399171 @default.
- W2338961167 hasConcept C502942594 @default.
- W2338961167 hasConcept C509974204 @default.
- W2338961167 hasConcept C71924100 @default.
- W2338961167 hasConceptScore W2338961167C126322002 @default.
- W2338961167 hasConceptScore W2338961167C141071460 @default.
- W2338961167 hasConceptScore W2338961167C2776194525 @default.
- W2338961167 hasConceptScore W2338961167C2776283816 @default.
- W2338961167 hasConceptScore W2338961167C2777931997 @default.
- W2338961167 hasConceptScore W2338961167C2778227246 @default.
- W2338961167 hasConceptScore W2338961167C2778880634 @default.
- W2338961167 hasConceptScore W2338961167C2779399171 @default.
- W2338961167 hasConceptScore W2338961167C502942594 @default.
- W2338961167 hasConceptScore W2338961167C509974204 @default.
- W2338961167 hasConceptScore W2338961167C71924100 @default.
- W2338961167 hasIssue "6" @default.
- W2338961167 hasLocation W23389611671 @default.
- W2338961167 hasOpenAccess W2338961167 @default.
- W2338961167 hasPrimaryLocation W23389611671 @default.
- W2338961167 hasRelatedWork W1481430939 @default.
- W2338961167 hasRelatedWork W1980057084 @default.
- W2338961167 hasRelatedWork W1991716601 @default.
- W2338961167 hasRelatedWork W2004164984 @default.
- W2338961167 hasRelatedWork W2203420696 @default.
- W2338961167 hasRelatedWork W2312555694 @default.
- W2338961167 hasRelatedWork W2338961167 @default.
- W2338961167 hasRelatedWork W2409692810 @default.
- W2338961167 hasRelatedWork W2460377520 @default.
- W2338961167 hasRelatedWork W30445624 @default.
- W2338961167 hasVolume "58" @default.
- W2338961167 isParatext "false" @default.
- W2338961167 isRetracted "false" @default.
- W2338961167 magId "2338961167" @default.
- W2338961167 workType "article" @default.